Literature DB >> 33542180

P21-activated kinase 5 potentiates the chemoresistant phenotype of liver cancer.

Ding-Guo Zhang1,2, Chan-Chan Gong1, Xiao-Jin Wu3, Xin Ren1, Randee S Sedaka2, Wei-Cong Chen1, Fu-Chun Huo1, Cheng Chen1, Wen-Qi Du1, Dong-Sheng Pei4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33542180      PMCID: PMC7862393          DOI: 10.1038/s41392-020-00409-y

Source DB:  PubMed          Journal:  Signal Transduct Target Ther        ISSN: 2059-3635


× No keyword cloud information.
  5 in total

Review 1.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; María Reig; Jordi Bruix
Journal:  Lancet       Date:  2018-01-05       Impact factor: 79.321

2.  p21-Activated kinase 5 affects cisplatin-induced apoptosis and proliferation in hepatocellular carcinoma cells.

Authors:  Ding-Guo Zhang; Jinling Zhang; Lin-Lin Mao; Jin-Xia Wu; Wen-Jia Cao; Jun-Nian Zheng; Dong-Sheng Pei
Journal:  Tumour Biol       Date:  2015-01-07

Review 3.  P-glycoprotein: from genomics to mechanism.

Authors:  Suresh V Ambudkar; Chava Kimchi-Sarfaty; Zuben E Sauna; Michael M Gottesman
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

4.  PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo.

Authors:  Ying-Chun Zhang; Fu-Chun Huo; Lu-Lu Wei; Chan-Chan Gong; Yao-Jie Pan; Jie Mou; Dong-Sheng Pei
Journal:  J Exp Clin Cancer Res       Date:  2017-10-17

5.  PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1.

Authors:  Fu-Chun Huo; Yao-Jie Pan; Tong-Tong Li; Jie Mou; Dong-Sheng Pei
Journal:  Cell Death Differ       Date:  2018-08-06       Impact factor: 15.828

  5 in total
  1 in total

Review 1.  The role of ceRNA-mediated diagnosis and therapy in hepatocellular carcinoma.

Authors:  Yi Shi; Ji-Bin Liu; Jing Deng; Da-Zhi Zou; Jian-Jun Wu; Ya-Hong Cao; Jie Yin; Yu-Shui Ma; Fu Da; Wen Li
Journal:  Hereditas       Date:  2021-11-10       Impact factor: 3.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.